QuidelOrtho Corp
Financial highlights
| Metric | FY December 28, 2025 | FY December 29, 2024 | FY December 31, 2023 | FY January 1, 2023 | FY January 2, 2022 |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.8B | $3.0B | $3.3B | $1.7B |
| Operating income | -$919.2M | -$2.0B | $139.1M | $843.7M | $906.0M |
| Cash from operations | $105.2M | $83.0M | $280.2M | $885.3M | $805.9M |
| Capital expenditure | $188.2M | $195.1M | $209.3M | $140.9M | $292.8M |
| Free cash flow | -$83.0M | -$112.1M | $70.9M | $744.4M | $513.1M |
| Share repurchases | $0 | $0 | $7.2M | $74.3M | $103.5M |
| Impairments | $700.7M | $1.8B | $0 | $0 | — |
| Total assets | $5.8B | $6.4B | $8.6B | $8.9B | $2.4B |
| Total liabilities | $3.8B | $3.4B | $3.6B | $3.9B | $501.0M |
| Total debt | $2.7B | $2.5B | $2.4B | $2.6B | $400,000 |
Shares outstanding 68.2M · Free float 80.9%
Annual filing data through FY ended December 28, 2025; float as of June 27, 2026.